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Invasive fungal diseases (IFD) due to opportunistic fungi are commonly treated using empirical 
antifungal therapy. Therefore, a comprehensive study of organisms associated with IFD is essential to 
define successful empiric therapies in each setting. Current diagnostic tests, such as culture, histology 
and serology are suboptimal, leading to delays in the initiation of antifungal therapies and resulting 
in high mortality rates despite the availability of several new antifungal agents. Using molecular 
methods to identify fungal pathogens directly from formalin-fixed, paraffin-embedded tissues is 
emerging as a diagnostic approach. The goal of this molecular approach is to complement 
conventional diagnostic tests through the reliable detection and identification of fungal nucleic acids 
or antigens in tissues so as to direct antiinfective therapies and improve patient outcomes. Here we 
review challenges and recent advances in the identification of fungal pathogens from tissue samples 
by conventional and molecular methods.  
 
Introduction  
Invasive fungal diseases (IFD) continue to be a serious threat to a growing number of patient groups, 
such as cancer patients, organ transplant recipients, the critically ill and other immunocompromised 
hosts. Despite considerably improved antifungal treatment options, these infections continue to be 
associated with mortality rates of up to 50% in some patient groups; this is in part due to the 
nonspecificity of clinical signs. Consequently, IFD are among the most often missed clinical diagnosis 
in cancer-, AIDS-, and critically ill patients [1-3]. In addition, limitations in diagnostic tests hinder the 
timely identification of causative agents, impeding the optimal selection of antifungal treatments. 
Fungi are widespread in the environment and a diverse array of fungi can be found on mucous 
membranes of humans. Using pyrosequencing, between 9 and 23 species, including culturable and 
uncultured fungi, have been detected from the oral mucosa of healthy people, making them 
potential agents of endogenous infections in immunocompromised states [4●]. This poses a 
significant problem to the interpretation of diagnostic tests based on the detection of fungi from 
non-sterile specimens. A distinction between colonization and IFD is often not possible. Cultures 
from involved tissues on the other hand, are only positive in 50% of cases with proven invasive 
infection [5,6]. Given these limitations in diagnostics, postmortem examinations classifying the 
morphology of fungal elements in tissues played a critical role in documenting changes in the 
epidemiology of IFD, such as a decrease in Candida-infections and an increase in mould infections 
during the 80´s and the increasing importance of mucormycosis in cancer patients in the 90´s [5,7]. 
However, it is becoming increasingly recognized, that the classification of IFD into these broad 
categories is not sufficient, as fungi with different in vitro susceptibilities can display identical 
3 
 
morphologies. Therefore, treatment decisions based on tissue morphology are not possible in many 
cases, reducing the chances for optimal patient treatment.  
In this review, we summarize limitations of culture and histopathology from tissue specimens in 
determining fungal infection etiology. We argue that tissue samples stored in pathology archives 
provide an important resource for applying molecular methods to advance our understanding of the 
etiology of IFD. The ability to accurately identify fungal etiology in tissue may also be useful as a gold 
standard to evaluate diagnostic tests from other surrogate samples, such as respiratory secretions or 
blood.   
 
Invasive fungal diseases can be proven by histopathology but species identification is limited  
The demonstration of fungal elements in tissue is of major importance for establishing the diagnosis 
of invasive fungal infections [8]. Several morphologic characteristics allow for the differentiation of 
several groups of fungi such as yeasts, hyaline moulds, dematiaceous fungi and the mucorales [9●●]. 
However, as several fungi share similar morphology in tissue samples, a species diagnosis is only 
rarely possible by histopathology. This limits the usefulness of histopathology in guiding antifungal 
treatment decisions. In addition, fungal classification by histopathology can be difficult. This is 
highlighted by a recent study comparing histopathologic classification of fungal elements in tissue 
with culture results from biopsy samples as a gold standard for species identification. Discrepant 
diagnoses were observed in 21% of the samples. Errors in the histopathologic classification resulted 
from the misidentification of septate, nonseptate and yeast forms, and a false sense of the ability to 
categorize fungal organisms by genus on the basis of morphologic features. Among the 8 
discrepancies with clinical follow-up available, two potential adverse clinical consequences were 
reported. As a consequence, the authors generated templates to provide standardized reporting and 
to deemphasize attempts at definitive species identification by fungal tissue morphology [10●●]. 
Additional factors that may impair the correct classification of fungal elements include antifungal 
pretreatment that can influence fungal morphology. Further complicating this picture, different 
fungal elements in tissue have been reported in 3-5% of proven invasive fungal infections in a review 
of autopsy cases performed in Japan.  While this suggests infections by different groups of fungi, such 
as hyalohyphomycetes with mucorales or yeasts with moulds, the validity on these classifications is 
difficult to assess in the absence of alternative tests, such as culture, which may prove the presence 
of mixed fungal pathogens in a tissue sample [11].  
The British Society for Medical Mycology proposed standards of care for patients with invasive fungal 
infections. Included therein are recommendations on how tissues from immunocompromised 
patients with suspected IFD should be stained, how fungal elements may be classified and how 
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positive results should be reported [12]. A subsequent audit demonstrated that less than 50% of 
pathology departments in the UK provided sufficient detailed descriptions of fungal morphology, as 
suggested by the guidelines [13]. Comparable data for other countries are not available.  
 
Cultivation of fungi from infected tissue is insensitive  
As the morphology of fungal elements in tissue is limited, while the diversity of fungal pathogens is 
great, cultivation from tissue specimens is useful for identifying fungal species. Growth of fungi from 
tissue specimens of patients with invasive fungal infections has been reported in 50% of cases with 
proven invasive fungal infection [6,14]. First, culture conditions such as temperature and duration of 
cultivation affect the recovery of moulds from various specimens [15]. Second, antifungal treatment 
is known to impair the recovery of fungi in cultures [16]. Third, several studies suggest that the 
mucorales are less likely to be recovered by culture from clinical specimens than other moulds. This 
may be partly due to the tissue processing prior to cultivation and also due to subsequent culture 
conditions [6,17,18]. Finally, fungi may be inhibited by co-cultured bacterial or fungal organisms, 
necessitating the use of selective media for sensitive cultivation of the pathogen. For example, 
Scedosporium species are slow growing moulds that can be cultured from the respiratory tract of 
patients with cystic fibrosis. These patients are often colonized with bacteria, yeasts, and moulds of 
the genus Aspergillus. In these patients, the cultivation of Scedosporium from respiratory secretions 
is much more likely when selective media are used that impair the growth of yeasts and Aspergillus 
species [19].  
Beside the lack of sensitivity of cultures in growing fungi from tissues of patients with proven IFD, it is 
possible that current culture and identification methods underestimate the frequency of mixed 
fungal infections. Up to 30% of patients at risk for developing candidemia, such as bone marrow 
transplant recipients and patients at surgical intensive care units, are colonized with more than one 
yeast species as assessed by conventional culture [20,21]. As these colonizing strains form the 
reservoir for endogenous infections in these patients, blood cultures may underestimate the 
frequency of mixed infections due to overgrowth with the dominant fungus; indeed, documented 
mixed infections are reported in 4% of patients with candidemia, and this should be considered a 
lower bounds for a more common problem. Interestingly, a recent report described the cultivation of 
more than one mould from respiratory specimens of patients with suspected invasive mould 
infections in 7% [22]. However, as histopathology may not be able to differentiate between most of 
these fungi and the cultivation of moulds may represent colonisation rather than infection, the 
frequency of mixed mold infections remains unknown and conventional diagnostic tests may not be 




Amplification methods are superior to culture in fungal species detection  
Due to the lack of sensitivity and specificity in the cultivation of fungi from infected tissue and 
challenges in the classification of fungal elements in tissue by histopathology, there is a growing 
interest in using molecular tests to detect and identify the etiologic agents of invasive fungal diseases 
from clinical samples. Studies using PCR to detect invasive mould infections from blood samples are 
limited by the low fungal burden in blood [23]. This and technical issues such as a suboptimal DNA 
extraction efficacy, contaminations by fungal DNA and the lack of a consensus on the optimal 
detection strategy limit the widespread use of this molecular approach [24]. While higher mould DNA 
concentrations are expected in bronchial secretions and tissue specimens, the differentiation 
between colonization and infection is becoming a critical issue when bronchial secretions are 
targeted for diagnostic purposes [25,26]. In contrast, recent studies suggest examples where PCR 
assays may already be successfully used to supplement conventional diagnostic tests in order to 
better characterize the etiology of IFD. A recent study in patients with deep-seated candidiasis 
suggests that PCR from blood is more sensitive in detecting yeasts as compared to blood-cultures, 
detecting yeasts in 89 versus 53% of patients. In addition, while blood cultures detected more than 
one yeast in 4%, in accordance with previous studies, PCR did so in 36%, suggesting that blood 
cultures underestimate the number mixed infections [●27]. Similarly, studies using PCR assays to 
detect moulds from tissue biopsies detect fungal DNA more often than culture grew moulds [6,18]. 
However, the interpretation of such findings is difficult to assess in the absence of a reliable gold 
standard for species level identification of invasive fungal infections.  
 
A reliable approach to identify the etiology of fungal pathogens from tissue using molecular 
methods: the value of combined amplification and hybridization methods 
A successful strategy to evaluate the etiology of invasive fungal infections needs both sensitive 
detection of pathogens and wide breadth of detection. To be useful as a basis for treatment 
decisions, single and multiple species should be correctly identified and a distinction between 
colonization and infection is helpful. Using molecular tools on formalin-fixed, paraffin-embedded 
tissue samples appears to be a promising path to generate diagnostic tools fulfilling these attributes. 
Among the most crucial steps in this approach is the extraction of fungal DNA from formalin-fixed, 
paraffin-embedded (ffpe) tissue specimens, the amplification of fungal DNA using PCR assays, the 
identification of amplicons using sequencing, and hybridization techniques able to localize fungal 
nucleic acids in pathologic tissue processes.    
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The DNA extraction procedure is critical for optimal DNA recovery from fungal pathogens. Using 
different commercial extraction kits, up to a million-fold differences in the amount of fungal DNA can 
be documented using quantitative PCR [28]. The extraction of fungal DNA from ffpe tissues of 
patients with proven IFD poses additional challenges, as documented by a lower amount of positive 
samples when compared to fresh tissue specimens [29,30]. By increasing the amount of tissue used 
for extraction, the detection of DNA of the mucorales from experimentally infected tissue could be 
improved, demonstrating that amplifiable fungal DNA may be retained below a detection limit in 
FFPE tissue samples [31]. However, increasing the amount of tissue is not always possible with 
clinical samples that may only have a limited amount of fungal material. In addition, this strategy 
may also inhibit the detection of fungal DNA in some cases by increasing the amount of non-target 
DNA or of PCR inhibitors. Several modifications of extraction procedures have been described in 
order to reverse damage of DNA inflicted by the fixation procedure in order to increase the yield of 
DNA extraction from FFPE tissue specimens. Among them, the application of heat prior to DNA-
extraction has been shown to increase the amount of amplifiable human DNA from FFPE tissue 
samples, probably by reversing cross linking of DNA with other biomolecules [32]. Recently, we have 
shown that this is also relevant for the extraction of fungal DNA from FFPE tissue specimens. 
Improvements in the amount of amplifiable human DNA up to 76-fold were documented, and the 
number of samples from which fungal DNA was amplified by broad range PCR and successfully 
identified by sequencing was improved [33]. Recent studies using PCR to identify fungal DNA from 
FFPE tissue specimens successfully identified fungal DNA in 70-80% of FFPE tissue samples in 
accordance with culture results, suggesting that this is a feasible approach [34,35].   
The target of PCR-assays used to amplify fungal DNA is critical for the identification of fungal 
pathogens. So far, multicopy genes such as the ribosomal rRNA genes have been used in order to 
provide sensitive species identification. Among these genes, conserved regions can be targeted to 
detect a broad coverage of fungi, while variable regions can be targeted to amplify DNA from distinct 
species or groups of fungi. Broad range fungal assays have been successfully used to determine the 
etiology of invasive fungal infections from FFPE tissue samples. Taxon-specific assays may be at least 
as sensitive in the detection of target organisms, but negative results have to be interpreted carefully 
as infections due to non-target fungi might be missed. This limitation might be diminished when 
assays targeting different groups of fungi are used [35]. The more inclusive target of broad-range 
assays may come at the price of an increased likelihood to detect contaminating DNA and a potential 
for cross-amplification of human DNA. However, assays can be designed to detect fungal DNA in an 
excess of human DNA [36]. This might be critical in tissue biopsies where lots of human DNA can be 
expected. Strategies to overcome contamination and adequate controls to address this issue have 
been proposed previously [24].   
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Most studies using PCR to detect fungal DNA in FFPE tissue specimens used Sanger-sequencing for 
the identification of PCR amplicons. A reliable differentiation up to the species level is possible 
depending on the target sequence. Difficulties in species identification may arise when mixed 
sequences are recovered either due to a mixed fungal infection or due to the presence of 
contamination with fungal DNA. An in-silico tool has been introduced to identify up to three bacteria 
from mixed chromatograms of bacterial DNA amplified by broad range bacterial PCR from mixed 
infections such as abscesses [37]. This approach might be useful for unraveling mixed 
chromatograms from fungal PCR assays as well. Further options to decipher mixed amplicons include 
the generation of clone libraries. Using this approach on clinical samples from mixed bacterial 
infections allows one to identify more agents than by PCR or culture [38,39●●]. Further species 
resolution is possible by next generation sequencing [39●●].  
Beside the identification of fungi by sequencing ribosomal RNA-genes, further applications for PCR 
and sequencing from tissue specimens may emerge. Vallor et al. successfully amplified the single 
copy FKS gene of A.fumigatus from tissue of an animal model of invasive aspergillosis [40]. With 
improvements in DNA extraction, such genes may successfully be targeted in FFPE tissues. Targeting 
single-copy genes may allow for the identification of molecular siblings, fungi that cannot reliably be 
differentiated by morphology or sequencing of ribosomal RNA-genes. The distinction between such 
sister species may have clinical implications as they may display different in vitro susceptibilities to 
antifungal agents [41,42●].  In addition, genetic elements related to in vitro resistance have been 
successfully detected directly from FFPE tissue of a patient with invasive Aspergillosis [43]. Such 
assays would be critical to use on FFPE tissue specimens to study reasons for antifungal treatment 
failure.  
Since its introduction in the late 1980´s fluorescence in situ hybridization (FISH) has become a widely 
used method for the identification and quantification of phylogenetically defined microbes in 
populations [44]. The basic steps of FISH include the fixation of samples to allow for the uptake of 
labeled synthetic DNA probes into target cells. Identification of microorganisms is achieved by 
binding of probes, designed to specifically hybridize with unique sequences of the ribosomal RNA of 
target organisms. After washing away unbound probe, hybridized cells can be identified by epi-
fluorescence microscopy. Due to the high rRNA content of cells, a sensitive detection and 
identification of microbes can be achieved [45].  
In the field of fungal diagnostics, FISH so far has been studied for the identification of agents of 
candidemia. DNA-probes have been described to differentiate between frequent isolates from 
patients with candidemia such as C. albicans, C. krusei, C. glabrata and C. parapsilosis cultivated from 
blood culture bottles [46]. In addition, DNA probes targeting Cryptococcus neoformans and 
8 
 
Cryptococcus gattii have been developed that differentiate these agents of cryptococcosis from other 
ascomycetes and basidiomycetous yeasts. Using these probes allowed for the identification of  
cryptococci directly from cerebrospinal fluid of patients with cryptococcosis [47].  More recently, 
peptide nucleic acid (PNA) probes, chemically modified DNA probes with increased affinity for 
complementary nucleic acids, have been used to discriminate between cultivated yeasts. Close 
relatives such as C. albicans and C. dubliniensis were differentiated [48]. Also, the distinction 
between frequent agents of candidemia, requiring different antifungal therapies such as C. albicans 
and C .glabrata was shown to be possible directly from positive blood culture bottles with 
sensitivities of 98.7 and 100% specificity in a multicenter trial. Of note, some species not regularly 
described as causes of candidemia, such as Candida nivariensis or Candida bacarensis were also 
stained with the probe aimed at the detection of C .glabrata, highlighting potential limitations in the 
species resolution with short probes [49]. Additional PNA- probes have been evaluated to further 
broaden the spectrum of cultivated yeasts (C. albicans, C. glabrata, C. tropicalis, C. krusei, C. 
parapsilosis) identifiable by PNA-probes. These yeast-species accounted for 99% of all yeasts 
cultivated in a diagnostic laboratory [50].  
These studies document that FISH using DNA- or PNA probes targeting rRNA can be used to 
differentiate between cultivated yeasts and suggest that their use may also be possible directly in 
uncultured samples. To our knowledge, these probes have not been used on fresh or formalin-fixed 
tissue samples from patients with deep-seated fungal infections.   
Most studies that sought to identify fungal pathogens in formalin-fixed, paraffin-embedded tissue 
samples used conventional DNA probes targeting the 5S, 18S or 28S rRNA for in situ hybridization. 
Using this approach, hybridization was achieved in 60-80 % of samples from yeast-infections, 
hyalohyphomycosis, phaeohyphomycosis and infections due to dimorphic fungi with documentation 
of hyphae by histology [51-54]. More recently, Montone used locked nucleic acid (LNA) probes, 
chemically modified DNA probes with increased affinity for the RNA-target with sequences identical 
to the DNA probes previously reported by Hayden. Using ffpe tissue samples from patients with 
culture confirmed coccidioidomycosis, aspergillosis and fusariosis, they reproduced the high 
specificity of the probes and suggested that the signal obtained by LNA-probes is superior to that 
obtained with DNA probes [55-57]. 
These studies using ffpe tissue specimens were performed with tissue obtained from culture proven 
clinical samples and tissue from proven non-target fungi as negative controls. While this approach of 
testing the sensitivity and specificity of probes is highly accurate for diseases caused by a limited 
number of causative agents, such as Histoplasma capsulatum, the definition of target species and 
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outside hits of these probes are not as clearly defined as for the probes reported for candidiasis and 
cryptococcosis.  
Recently, reports applying FISH-probes to study the etiology of IFD from tissue specimens used 
cultivated fungi to experimentally evaluate target organisms and outside hits of the probes. Shinozaki 
developed a probe targeting the 28S rRNA of Fusarium spp.. They used a target sequence conserved 
among frequent agents of Fusariosis that displayed several mismatches in the target region of other 
frequent fungal pathogens such as Aspergillus, Candida and the mucorales making hybridization with 
these fungi unlikely. The specificity of the probe was assessed using formalin fixed, paraffin 
embedded hyphae from a panel of type strains and tissue from mice infected with Candida, 
Aspergillus, mucorales, Fusarium and Pseudallescheria. The designed Fusarium-probe was found to 
specifically stain hyphae from cultivated type strains and hyphal elements in tissues from animals 
with fusariosis [58]. In a comparable approach, we used a panel of type strains to generate DNA 
probes to identify Candida spp. and Aspergillus spp. in tissue samples by FISH and compared the 
results to those obtained by broad-range fungal PCR targeting the 28S ribosomal RNA-Gene with 
sequencing of the amplicons [34]. In this study, PCR was more successful in identifying the etiology of 
IFD. As in previous studies using ISH, the distinction of the probe signal was impaired in necrotic 
tissue background in samples from mould infections [34,51,52]. This limitation may be overcome by 
superior probe chemistries such as PNA-, or LNA probes [45]. In addition, the hybridization signals 
can be restricted to parts of fungal elements in tissue [34,58,59]. This is in accordance with data 
demonstrating that rRNA signals obtained by PNA probes is most intense in the apical compartment 
of hyphae [60].  
Ultimately, a panel of probes with well-defined target species detecting frequent agents of IFD could 
be designed. Recently, online tools allowing the prediction of probes generating strong signals have 
been introduced. These tools will help characterize probes to reduce time needed for experiments 
[61]. Using such fungal probes with non-specific probes labeled with different fluorophores may help 
visualize uncommon agents and localize them to the pathologic process in tissue. Improvements in 
microscopy may facilitate the application of different numbers of fluorescently labeled probes 
allowing for the detection of multiple species in a single sample [62]. 
 
Emerging applications of molecular tissue diagnosis  
Tissues samples from patients with invasive fungal infections are crucial for understanding the 
etiology on IFD. Molecular tests are emerging as tools to characterize the etiology of IFD from FFPE 
tissue specimens, circumventing shortcomings in culture and histopathology. While amplification 
based methods offer sensitive detection and identification of organisms, hybridization tests localize 
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and identify fungi within tissue pathology, proving causality. Several attributes may allow a 
comprehensive study of organisms associated with IFD. First, culture negative mould infections 
constitute up to 60 % of all mould infections found at autopsies in cancer patients. Molecular 
methods may provide a clear picture of the etiology of mould infections in these patients. Second, 
polymicrobial infections in cancer patients are increasingly being recognized and can be a therapeutic 
challenge. They may originate from abdominal infections such as neutropenic colitis [63]. Mixed 
infections are diagnosed in up to 23% of patients in Candidemia [64]. In polymicrobial communities, 
microbes interact, either directly, by secreted molecules or via competition for nutrients [65]. These 
interactions may modify antimicrobial susceptibility [66] and therefore have therapeutic or 
prognostic implications. Deciphering the etiology may stimulate research on interactions between 
microorganisms [67]. Third, the etiology of IFD is difficult to assess in patients colonized with multiple 
fungi, such as patients with cystic fibrosis. While IFD may be rare in these patients, they do occur 
after lung transplantation, that is an increasingly used therapeutic option to treat end stage 
pulmonary failure and that is associated with mortality rates of 29% despite antifungal therapy [68].  
 
Conclusion 
The tissue diagnosis of IFD is important for understanding changes in the epidemiology of 
opportunistic fungal infections. The proper histopathologic description of fungal elements in tissues 
is critically needed but current technology falls short and cultivation suffers from similar challenges. 
The use of ffpe tissue samples to study the etiology of IFD by molecular tests is a promising strategy. 
A combined approach using amplification techniques with sequencing and hybridization based assays 
has the potential to overcome limitations of culture and histopathology. A better understanding of 
the etiology of invasive fungal infections will improve empiric antifungal therapies, may guide 
treatment decisions in patients with break-through infections, and can help improve the 






Figure 1: Gut biopsy of a patient with relapsed acute myelogenous leukemia who died from sepsis. 
While blood cultures were sterile under antimicrobial therapy, Fluorescence in situ hybridization 
(FISH) targeting different ribosomal RNA sequences of microbes documents a mixed infection. Cocci 
and rods (stained with the bacterial probe EUB 338 [45], labeled with the fluorescent dye Cy3 (coded 
as organge) and yeasts (stained with the fungal probe Cand 317 [34] labeled with the dye Cy5 (coded 
as red) between human cells. Nuclei of human-, and fungal cells stained with 4´,6-diamidino-2-
phenylindole (DAPI) (blue). The yeast was identified as C.albicans by sequencing of the amplicons of 





1. Pastores, S. M., A. Dulu, et al. Premortem clinical diagnoses and postmortem autopsy 
findings: discrepancies in critically ill cancer patients. Crit Care. 2007; 11(2): R48.  
 
2. Antinori, S., M. Nebuloni, et al. Trends in the postmortem diagnosis of opportunistic invasive 
fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed 
between 1984 and 2002. Am J Clin Pathol 2009; 132(2): 221-227.  
 
3. Tejerina, E., A. Esteban, et al. Clinical diagnoses and autopsy findings: Discrepancies in 
critically ill patients. Crit Care Med 2012;40(3): 842-846. 
 
4. ● Ghannoum, M. A., R. J. Jurevic, et al. Characterization of the oral fungal microbiome 
(mycobiome) in healthy individuals. PLoS Pathog 2010; 6(1): e1000713. This study highlights 
the diversity of fungi found on mucous membranes of healthy people. 
 
5. Chamilos, G., M. Luna, et al. Invasive fungal infections in patients with hematologic 
malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-
2003). Haematologica 2006; 91(7): 986-989. 
 
6. Rickerts, V., S. Mousset, et al. Comparison of histopathological analysis, culture, and 
polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. 
Clin Infect Dis 2007; 44(8): 1078-1083. 
 
7. Groll, A. H., P. M. Shah, et al. Trends in the postmortem epidemiology of invasive fungal 
infections at a university hospital. J Infect 1996; 33(1): 23-32. 
 
8. De Pauw, B., T. J. Walsh, et al. Revised definitions of invasive fungal disease from the 
European Organization for Research and Treatment of Cancer/Invasive Fungal Infections 
Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses 
Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46(12): 1813-1821. 
 
9. ●● Guarner, J. and M. E. Brandt. Histopathologic diagnosis of fungal infections in the 21st 
century. Clin Microbiol Rev 2011; 24(2): 247-280. Authoritative review on diagnostic aspects 
of histopathology of invasive fungal infections.   
 
10. ●● Sangoi, A. R., W. M. Rogers, et al. Challenges and pitfalls of morphologic identification of 
fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a 
single institution." Am J Clin Pathol 2009; 131(3): 364-375. Evaluates discrepancies between 
histopathlogic-, and culture results. Suggest steps to improve reporting on results of 
histopathology of invasive fungal infections.   
 
11. Kume, H., T. Yamazaki, et al. Epidemiology of visceral mycoses in autopsy cases in Japan: 
comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of 
Pathological Autopsy Cases in Japan. Med Mycol J 2011;52(2): 117-127. 
 
12. Denning, D. W., C. C. Kibbler, et al. British Society for Medical Mycology proposed standards 
of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3(4): 230-240. 
 
13. Schelenz, S., R. A. Barnes, et al. Standards of care for patients with invasive fungal infections 
within the United Kingdom: a national audit. J Infect 2009;58(2): 145-153.  
13 
 
14. Tarrand, J. J., X. Y. Han, et al. Aspergillus hyphae in infected tissue: evidence of physiologic 
adaptation and effect on culture recovery. J Clin Microbiol 2005;43(1): 382-386. 
 
15. Tarrand, J. J., M. Lichterfeld, et al. Diagnosis of invasive septate mold infections. A correlation 
of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 
2003;119(6): 854-858. 
 
16. Riedel, S., S. W. Eisinger, et al. Comparison of BD Bactec Plus Aerobic/F medium to 
VersaTREK Redox 1 blood culture medium for detection of Candida spp. in seeded blood 
culture specimens containing therapeutic levels of antifungal agents. J Clin Microbiol 2011; 
49(4): 1524-1529. 
 
17. Kontoyiannis, D. P., G. Chamilos, et al. Increased culture recovery of Zygomycetes under 
physiologic temperature conditions. Am J Clin Pathol 2007; 127(2): 208-212. 
 
18. Lass-Florl, C., G. Resch, et al. The value of computed tomography-guided percutaneous lung 
biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect 
Dis 2007; 45(7): e101-104. 
 
19. Blyth, C. C., A. Harun, et al. Detection of occult Scedosporium species in respiratory tract 
specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol 2010; 
48(1): 314-316. 
 
20. Marr, K. A., K. Seidel, et al. Candidemia in Allogeneic Blood and Marrow Transplant 
Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole. Journal 
of Infectious Diseases 2010; 181(1): 309-316. 
 
21. Magill, S. S., S. M. Swoboda, et al. The epidemiology of Candida colonization and invasive 
candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-
up to a randomized clinical trial. Ann Surg (2009); 249(4): 657-665. 
 
22. Purcell, J., J. McKenna, et al. Mixed mould species in laboratory cultures of respiratory 
specimens: how should they be reported, and what are the indications for susceptibility 
testing? J Clin Pathol 2011; 64(6): 543-545. 
 
23. Springer, J., J. Loeffler, et al. Pathogen-specific DNA enrichment does not increase sensitivity 
of PCR for diagnosis of invasive aspergillosis in neutropenic patients. J Clin Microbiol 2011; 
49(4): 1267-1273. 
 
24. Khot, P. D. and D. N. Fredricks. PCR-based diagnosis of human fungal infections. Expert Rev 
Anti Infect Ther 2009;7(10): 1201-1221. 
 
25. Bretagne, S., J. M. Costa, et al. Detection of Aspergillus species DNA in bronchoalveolar 
lavage samples by competitive PCR. J Clin Microbiol 1995; 33(5): 1164-1168. 
 
26. Lengerova, M., I. Kocmanova, et al. Detection and Measurement of Fungal Burden in a 
Guinea Pig Model of Invasive Pulmonary Aspergillosis by Novel Quantitative Nested Real-
Time PCR Compared with Galactomannan and (1,3)-beta-D-Glucan Detection. J Clin Microbiol 
2012; 50(3): 602-608. 
 
27. ● Nguyen, M. H., M. C. Wissel, et al. Performance of Candida real-time polymerase chain 
reaction, beta-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin 
14 
 
Infect Dis 2012; 54(9): 1240-1248. Suggest superior sensitivity of PCR in detecting etiologic 
agents of deep seated candidiasis, including mixed infections as compared with blood 
cultures. 
  
28. Fredricks, D. N., C. Smith, et al. Comparison of six DNA extraction methods for recovery of 
fungal DNA as assessed by quantitative PCR. J Clin Microbiol 2005; 43(10): 5122-5128. 
 
29. Willinger, B., A. Obradovic, et al. Detection and identification of fungi from fungus balls of the 
maxillary sinus by molecular techniques. J Clin Microbiol 2003; 41(2): 581-585. 
 
30. Lau, A., S. Chen, et al. Development and clinical application of a panfungal PCR assay to 
detect and identify fungal DNA in tissue specimens. J Clin Microbiol 2007; 45(2): 380-385. 
 
31. Dannaoui, E., P. Schwarz, et al. Molecular detection and identification of zygomycetes 
species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a 
collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 
Fungal Infection Study Group (EFISG) evaluation. J Clin Microbiol 2010; 48(6): 2043-2046. 
 
32. Gilbert, M. T., T. Haselkorn, et al. The isolation of nucleic acids from fixed, paraffin-
embedded tissues-which methods are useful when? PLoS ONE 2007; 2(6): e537. 
 
33. Rickerts, V., P. D. Khot, et al. Enhanced fungal DNA-extraction from formalin-fixed, paraffin-
embedded tissue specimens by application of thermal energy. Med Mycol 2012 in press. 
  
34. ● Rickerts, V., P. D. Khot, et al. Comparison of quantitative real time PCR with Sequencing 
and ribosomal RNA-FISH for the identification of fungi in Formalin fixed, paraffin-embedded 
tissue specimens. BMC Infect Dis 2011; 11: 202. Explores the combined use of quantitative 
realtime PCR and fluorescence in situ hybridisation in an attempt to characterise the etiology 
of invasive fungal infections. 
 
35. Hammond, S. P., R. Bialek, et al. Molecular methods to improve diagnosis and identification 
of mucormycosis. J Clin Microbiol 2011; 49(6): 2151-2153. 
 
36. Khot, P. D., D. L. Ko, et al. Sequencing and analysis of fungal rRNA operons for development 
of broad-range fungal PCR assays. Appl Environ Microbiol 2009; 75(6): 1559-1565. 
 
37. Kommedal, O., B. Karlsen, et al. Analysis of mixed sequencing chromatograms and its 
application in direct 16S rRNA gene sequencing of polymicrobial samples." J Clin Microbiol 
2008; 46(11): 3766-3771. 
 
38. Fredricks, D. N., M. M. Schubert, et al. Molecular identification of an invasive gingival 
bacterial community. Clin Infect Dis 2005; 41(1): e1-4. 
 
39. ●● Al Masalma, M., F. Armougom, et al. The expansion of the microbiological spectrum of 
brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clin Infect Dis 2009; 
48(9): 1169-1178. Demonstrates an increased number of identified agents in cerebral 
abscesses, including bacteria not previously known to be associated with cerebral abscesses. 
 
40. Vallor, A. C., W. R. Kirkpatrick, et al. Assessment of Aspergillus fumigatus burden in 
pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, 
and quantitative culture. Antimicrob Agents Chemother 2008; 52(7): 2593-2598. 
15 
 
41. Baddley, J. W., K. A. Marr, et al. Patterns of susceptibility of Aspergillus isolates recovered 
from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin 
Microbiol 2009; 47(10): 3271-3275. 
 
42. Balajee, S. A., A. M. Borman, et al. Sequence-based identification of Aspergillus, fusarium, 
and mucorales species in the clinical mycology laboratory: where are we and where should 
we go from here? J Clin Microbiol 2009; 47(4): 877-884. 
 
43. van der Linden, J. W., E. Snelders, et al. Rapid diagnosis of azole-resistant aspergillosis by 
direct PCR using tissue specimens. J Clin Microbiol 2010; 48(4): 1478-1480. 
  
44. DeLong, E. F., G. S. Wickham, et al. Phylogenetic stains: ribosomal RNA-based probes for the 
identification of single cells. Science 1989; 243(4896): 1360-1363. 
 
45. Amann, R. and B. M. Fuchs. Single-cell identification in microbial communities by improved 
fluorescence in situ hybridization techniques. Nat Rev Microbiol 2008; 6(5): 339-348. 
 
46. Kempf, V. A. J., K. Trebesius, et al. Fluorescent In Situ Hybridization Allows Rapid 
Identification of Microorganisms in Blood Cultures. J Clin Microbiol 2000; 38(2): 830-838. 
 
47. Martins, M. L., A. S. Ferreira, et al. Direct and specific identification of Cryptococcus 
neoformans in biological samples using fluorescently labelled DNA probes. Eur J Clin 
Microbiol Infect Dis 2010; 29(5): 571-576. 
 
48. Oliveira, K., G. Haase, et al. Differentiation of Candida albicans and Candida dubliniensis by 
fluorescent in situ hybridization with peptide nucleic acid probes. J Clin Microbiol 2001; 
39(11): 4138-4141. 
 
49. Shepard, J. R., R. M. Addison, et al. Multicenter evaluation of the Candida albicans/Candida 
glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-
color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin 
Microbiol 2008; 46(1): 50-55. 
 
50. Reller, M. E., A. B. Mallonee, et al. Use of peptide nucleic acid-fluorescence in situ 
hybridization for definitive, rapid identification of five common Candida species.  J Clin 
Microbiol 2007; 45(11): 3802-3803. 
 
51. Hayden, R. T., X. Qian, et al. In situ hybridization for the identification of yeastlike organisms 
in tissue section. Diagn Mol Pathol 2001; 10(1): 15-23. 
 
52. Hayden, R. T., X. Qian, et al. In situ hybridization for the identification of filamentous fungi in 
tissue section. Diagn Mol Pathol 2002; 11(2): 119-126. 
 
53. Hayden, R. T., P. A. Isotalo, et al. In situ hybridization for the differentiation of Aspergillus, 
Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol 2003; 12(1): 21-
26. 
 
54. Montone, K. T., V. A. Livolsi, et al. Rapid In-situ hybridization for dematiaceous fungi using a 
broad-spectrum oligonucleotide DNA probe. Diagn Mol Pathol 2011; 20(3): 180-183. 
 
55. Montone, K. T. and M. D. Feldman In situ detection of aspergillus 18s ribosomal RNA 
Sequences using a terminally biotinylated locked nucleic acid (LNA) probe. Diagn Mol Pathol 
16 
 
2009; 18(4): 239-242. 
 
56. Montone, K. T. Differentiation of Fusarium from Aspergillus species by colorimetric in situ 
hybridization in formalin-fixed, paraffin-embedded tissue sections using dual fluorogenic-
labeled LNA probes. Am J Clin Pathol 2009; 132(6): 866-870. 
 
57. Montone, K. T., L. A. Litzky, et al. In situ hybridization for Coccidioides immitis 5.8S ribosomal 
RNA sequences in formalin-fixed, paraffin-embedded pulmonary specimens using a locked 
nucleic acid probe: a rapid means for identification in tissue sections. Diagn Mol Pathol 2010; 
19(2): 99-104. 
 
58. Shinozaki, M., Y. Okubo, et al. Identification of Fusarium species in formalin-fixed and 
paraffin-embedded sections by in situ hybridization using peptide nucleic acid probes. J Clin 
Microbiol 2011; 49(3): 808-813.  
 
59. Park, C. S., J. Kim, et al. Detection of Aspergillus ribosomal RNA using biotinylated 
oligonucleotide probes. Diagn Mol Pathol 1997; 6(5): 255-260. 
 
60. Teertstra, W. R., L. G. Lugones, et al. In situ hybridisation in filamentous fungi using peptide 
nucleic acid probes. Fungal Genet Biol 2004; 41(12): 1099-1103. 
 
61. Yilmaz, L. S., S. Parnerkar, et al. mathFISH, a web tool that uses thermodynamics-based 
mathematical models for in silico evaluation of oligonucleotide probes for fluorescence in 
situ hybridization. Appl Environ Microbiol 2011; 77(3): 1118-1122. 
 
62. Valm, A. M., J. L. Welch, et al. Systems-level analysis of microbial community organization 
through combinatorial labeling and spectral imaging. Proc Natl Acad Sci U S A 2011; 108(10): 
4152-4157. 
 
63. Rolston, K. V., G. P. Bodey, et al. Polymicrobial infection in patients with cancer: an 
underappreciated and underreported entity. Clin Infect Dis 2007; 45(2): 228-233.  
 
64. Klotz, S. A., B. S. Chasin, et al. Polymicrobial bloodstream infections involving Candida 
species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 2007; 
59(4): 401-406. 
 
65. Klotz, S. A., N. K. Gaur, et al. Candida albicans Als proteins mediate aggregation with bacteria 
and yeasts. Med Mycol 2007; 45(4): 363-370. 
 
66. Harriott, M. M. and M. C. Noverr. Candida albicans and Staphylococcus aureus form 
polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother 
2009; 53(9): 3914-3922. 
 
67. Peleg, A. Y., E. Tampakakis, et al. Prokaryote-eukaryote interactions identified by using 
Caenorhabditis elegans. Proc Natl Acad Sci U S A 2008; 105(38): 14585-14590. 
 
68. Vadnerkar, A., C. J. Clancy, et al. Impact of mold infections in explanted lungs on outcomes of 
lung transplantation. Transplantation 2010; 89(2): 253-260. 
 
 
